Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drug Cocktails for Cancer, Heart Disease Get Streamlined Review From FDA
Bloomberg
Tuesday, December 14, 2010 - 5:34pm
tags:
FDA, Roche, Sanofi, drug cocktails, cancer, Novartis, Pfizer, GSK, Merck, heart disease
Pfizer Joins the E-Sampling Crowd: How it Assuaged Sales Reps’ Concerns
WSJ Online
Tuesday, December 14, 2010 - 5:33pm
tags:
e-sampling, Pfizer, drug reps
Legal Experts React to Health Care Ruling
National Review
Tuesday, December 14, 2010 - 12:44pm
tags:
healthcare reform
Obamacare Defenders May Have Precedent They Need
Forbes
Tuesday, December 14, 2010 - 12:28pm
tags:
healthcare reform
Critics eye Mass. Health after Obamacare ruling
Boston Herald
Tuesday, December 14, 2010 - 12:25pm
tags:
healthcare reform
Pfizer names Lorch after Kindler exit
FT.com
Tuesday, December 14, 2010 - 11:28am
tags:
Pfizer, Jeff Kindler, George Lorch
Lilly Suspends Late-Stage Trial for Melanoma Drug in Which 12 People Died
Bloomberg
Tuesday, December 14, 2010 - 11:27am
tags:
melanoma, Eli Lilly, clinical trials, tasisulam
Status update: Pharma skeptical of social media
Fierce Pharma
Tuesday, December 14, 2010 - 11:25am
tags:
social media
FDA’s Brilinta Vote Seen Key for AstraZeneca Share Price
WSJ Online
Tuesday, December 14, 2010 - 11:25am
tags:
FDA, Brilinta, AstraZeneca, blood thinners
Charles River Laboratories expects 2011 profit growth, raises 2010 guidance
Yahoo/AP
Tuesday, December 14, 2010 - 11:12am
tags:
Charles River Laboratories, guidance
Amgen shares rise after positive study data
Marketwatch
Tuesday, December 14, 2010 - 11:11am
tags:
Amgen, prostate cancer, Xgeva
Ym Biosciences Prices $40 Million Public Offering
Yahoo
Tuesday, December 14, 2010 - 11:07am
tags:
stock offering, YM BioSciences
Glaxo on Acquisition Spree
Yahoo/Zacks.com
Tuesday, December 14, 2010 - 11:06am
tags:
GSK, M&A, Nanjing MeiRui, Pfizer, Maxinitrition
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Seeking Alpha
Tuesday, December 14, 2010 - 11:04am
tags:
FDA, major depressive disorder, Forest Labs, GSK, Eli Lilly, Merck, Clinical Data, Vilazodone, Pfizer
Daiichi Sankyo US unit buys Roxro Pharma to gain pain drug SPRIX
The Pharma Letter
Tuesday, December 14, 2010 - 11:03am
tags:
Roxro, M&A, Daiichi Sankyo
The End of Endo Pharma's Bull Run
Barron's
Tuesday, December 14, 2010 - 7:28am
tags:
Endo
Amgen Drug Prevents Prostate Cancer From Spreading To Bone
Forbes
Monday, December 13, 2010 - 9:14pm
tags:
Amgen, prostate cancer, Xgeva
Buyback, dividend could lift Pfizer stock-Barron's
Reuters
Monday, December 13, 2010 - 8:34pm
tags:
Pfizer, dividends, stock buyback
Eli Lilly suspends skin cancer study over safety concerns
Yahoo/AP
Monday, December 13, 2010 - 8:33pm
tags:
Eli Lilly, skin cancer, tasisulam
Big Pharma's Lost Stock Market Decade
Seeking Alpha
Monday, December 13, 2010 - 8:32pm
tags:
Big Pharma, Abbott Laboratories, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.